by Sharon Kuttner | Jul 29, 2020 | Alzheimer's/Dementia Research
Abstract Background We report on the first case of successful treatment for post-anesthesia dementia with perispinal etanercept injection combined with hyperbaric oxygen therapy. Case presentation Our patient was a 77-year-old Caucasian man of Mexican ethnicity who...
by Sharon Kuttner | Jul 29, 2020 | Alzheimer's/Dementia Research
Abstract Background: Vascular dementia (VD) is a common type of disease in the elderly. Numerous clinical trials have suggested that hyperbaric oxygen is an effective and safe complementary therapy for aging-related disorders. However, there is no reliable systematic...
by Sharon Kuttner | Jul 29, 2020 | Alzheimer's/Dementia Research
Abstract A 58-year-old female was diagnosed with Alzheimer’s dementia (AD) which was rapidly progressive in the 8 months prior to initiation of hyperbaric oxygen therapy (HBOT). Fluorodeoxyglucose (FDG) positron emission tomography (PET) brain imaging demonstrated...
by Sharon Kuttner | Jul 29, 2020 | Alzheimer's/Dementia Research
Abstract Introduction: It has been reported that environmental factors such as hypoxia could contribute to the pathogenesis of Alzheimer’s disease (AD). Therapeutics like hyperbaric oxygen treatment, which improves tissue oxygen supply and ameliorates hypoxic...
by Sharon Kuttner | Jul 29, 2020 | Alzheimer's/Dementia Research
Abstract Purpose To investigate the effects of hyperbaric oxygen (HBO) pretreatment on cognitive decline and neuronal damage in an Alzheimer’s disease (AD) rat model. Materials and Methods Rats were divided into three groups: normal saline (NS), AD, and HBO+AD. In the...
by Sharon Kuttner | Jul 29, 2020 | Alzheimer's/Dementia Research
Abstract Background: Hyperbaric oxygen (HBO) and Ginkgo biloba extract (e.g., EGB 761) were shown to ameliorate cognitive and memory impairment in Alzheimer’s disease (AD). However, the exact mechanism remains elusive. The aim of the present study was to...
